Skip to navigation menu Skip to content
Inhaled Medical Aerosols and Respiratory Therapeutic Interventions to Promote Neonatal and Pediatric Lung Health

DiBlasi Lab

The DiBlasi Lab aims to develop and evaluate inhaled therapies and life-support systems for newborns and children with life-threatening respiratory failure. Working with worldwide collaborators, industry partners and clinical staff at Seattle Children's Hospital, the lab conducts innovative pre-clinical research to investigate respiratory therapies and devices' therapeutic benefits and responses to promote gas exchange, lung health, growth and development.

The lab focuses on novel drug delivery formulations and devices for administering inhaled medical aerosols and specialty gases, improving airway secretion clearance and optimizing mechanical ventilation. Laboratory findings have been translated into clinical trials and resulted in several devices and therapies that are currently being used clinically in children. Ultimately, we aim to improve respiratory care for children in all low- and well-resourced clinical settings.

By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.

Accept All Cookies